GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » FCF Margin %

Cangene (FRA:YGE) FCF Margin % : -28.93% (As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cangene's Free Cash Flow for the three months ended in Oct. 2013 was €-5.22 Mil. Cangene's Revenue for the three months ended in Oct. 2013 was €18.04 Mil. Therefore, Cangene's FCF Margin % for the quarter that ended in Oct. 2013 was -28.93%.

As of today, Cangene's current FCF Yield % is 0.00%.

The historical rank and industry rank for Cangene's FCF Margin % or its related term are showing as below:

FRA:YGE' s FCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 6.23
Current: 6.23


During the past 13 years, the highest FCF Margin % of Cangene was 6.23%. The lowest was 0.00%. And the median was 0.00%.

FRA:YGE's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -148.24 vs FRA:YGE: 6.23


Cangene FCF Margin % Historical Data

The historical data trend for Cangene's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene FCF Margin % Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.04 -5.33 5.28 -8.44 13.11

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.88 9.72 8.36 32.80 -28.93

Competitive Comparison of Cangene's FCF Margin %

For the Biotechnology subindustry, Cangene's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cangene's FCF Margin % falls into.



Cangene FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cangene's FCF Margin for the fiscal year that ended in Jul. 2013 is calculated as

FCF Margin=Free Cash Flow (A: Jul. 2013 )/Revenue (A: Jul. 2013 )
=12.749/97.269
=13.11 %

Cangene's FCF Margin for the quarter that ended in Oct. 2013 is calculated as

FCF Margin=Free Cash Flow (Q: Oct. 2013 )/Revenue (Q: Oct. 2013 )
=-5.22/18.043
=-28.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cangene's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines